Da Volterra
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI) (NCT03710694) | Da Volterra | 2018-10-31 |
Track Da Volterra automatically
Every clearance here is in the API, with alerts when new ones post.